|
1. FDA approves 1st oral COVID-19 prevention drug Full story
2. Mounjaro outperforms other GLP-1s in early Type 2 diabetes treatment: Study Full story
3. Is your health system capturing the full enterprise value of precision genomics? Find out here.
4. New oral drug shows responses across 6 tumor types Full story
5. Eli Lilly gives hospitals 5 days to comply with 340B policy Full story
6. FQHC sees 25% more weekly patient encounters — without sacrificing work-life balance. See how here.
7. GLP-1 use linked to lower breast cancer risk: Study Full story
8. ADHD drug hits FDA snag Full story
Becker’s Learning Opportunities
9. Behavioral health referrals often fall short. See how to double first-visit attendance here.
10. Cottage Health + Sinai Chicago are expanding safety-net care through specialty pharmacy and 340B reinvestment — details here.
11. Compliance gaps in ASC sterile processing expose legal and financial risk. The response from leaders here.
12. Becker’s resources don’t stop here — explore more webinars and whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
